Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/24 16:08 | 8/8/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Baumgartner Robert V | MN | D | 1 | S.d | -1,154 | 72.10 | 0 | -16 | 43 | D | ||||||||||||||||
5/16/24 16:17 | 5/14/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Higgins John L | MN | D | 1 | S.d | -335 | 83.84 | 0 | -4 | 37 | D | ||||||||||||||||
3/11/24 16:04 | 3/7/24 | TECH | Health | BioPrd | Biological Products, (No Diag | Nusse Roeland | MN | D | 2 | S.d | -1,519 | 78.52 | 0 | -19 | 52 | D | ||||||||||||||||
7/25/23 17:27 | 7/21/23 | TECH | Health | BioPrd | Biological Products, (No Diag | Kummeth Charles R. | MN | DO | CEO | 1 | S.d | -7,069 | 88.36 | 0 | -80 | 1,260 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |